Immune response in COVID-19: A review
- PMID: 32718895
- PMCID: PMC7359800
- DOI: 10.1016/j.jiph.2020.07.001
Immune response in COVID-19: A review
Abstract
The immune system protects against viruses and diseases and produces antibodies to kill pathogens. This review presents a brief overview of the immune system regarding its protection of the human body from COVID-19; illustrates the process of the immune system, how it works, and its mechanism to fight virus; and presents information on the most recent COVID-19 treatments and experimental data. Various types of potential challenges for the immunes system are also discussed. At the end of the article, foods to consume and avoid are suggested, and physical exercise is encouraged. This article can be used worldwide as a state of the art in this critical moment for promising alternative solutions related to surviving the coronavirus.
Keywords: COVID-19; Case study; Data analysis; Immunity system; Potential challenges.
Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
The authors declared that there is no conflict of interest.
Figures
Similar articles
-
Audio Interview: Capitalizing on Immune Responses to Covid-19.N Engl J Med. 2020 May 21;382(21):e93. doi: 10.1056/NEJMe2019020. N Engl J Med. 2020. PMID: 32433859 No abstract available.
-
Progress and Challenges in the Development of COVID-19 Vaccines and Current Understanding of SARS-CoV-2- Specific Immune Responses.J Microbiol Biotechnol. 2020 Aug 28;30(8):1109-1115. doi: 10.4014/jmb.2006.06006. J Microbiol Biotechnol. 2020. PMID: 32627758 Free PMC article. Review.
-
Audio Interview: Approaches to Covid-19 Vaccines and Antivirals.N Engl J Med. 2020 Apr 23;382(16):e58. doi: 10.1056/NEJMe2012889. N Engl J Med. 2020. PMID: 32320592 No abstract available.
-
What about the original antigenic sin of the humans versus SARS-CoV-2?Med Hypotheses. 2020 Sep;142:109824. doi: 10.1016/j.mehy.2020.109824. Epub 2020 May 7. Med Hypotheses. 2020. PMID: 32408068 Free PMC article. No abstract available.
-
Immunotherapeutic approaches to curtail COVID-19.Int Immunopharmacol. 2020 Nov;88:106924. doi: 10.1016/j.intimp.2020.106924. Epub 2020 Aug 21. Int Immunopharmacol. 2020. PMID: 32877828 Free PMC article. Review.
Cited by
-
The role of HLA genetic variants in COVID-19 susceptibility, severity, and mortality: A global review.J Clin Lab Anal. 2024 Jan;38(1-2):e25005. doi: 10.1002/jcla.25005. Epub 2024 Jan 22. J Clin Lab Anal. 2024. PMID: 38251811 Free PMC article. Review.
-
SARS-CoV-2 Humoral Immune Responses in Convalescent Individuals Over 12 Months Reveal Severity-Dependent Antibody Dynamics.medRxiv [Preprint]. 2023 Dec 7:2023.12.05.23299462. doi: 10.1101/2023.12.05.23299462. medRxiv. 2023. PMID: 38106077 Free PMC article. Preprint.
-
Hematological, inflammatory, and novel biomarkers assessment as an eminent strategy for clinical management of COVID-19.Heliyon. 2023 Nov 28;9(12):e22896. doi: 10.1016/j.heliyon.2023.e22896. eCollection 2023 Dec. Heliyon. 2023. PMID: 38076059 Free PMC article.
-
Different Prognostic Role of Soluble PD-L1 in the Course of Severe and Non-Severe COVID-19.J Clin Med. 2023 Oct 27;12(21):6812. doi: 10.3390/jcm12216812. J Clin Med. 2023. PMID: 37959277 Free PMC article.
-
Pharmacogenomic Landscape of Ivermectin and Selective Antioxidants: Exploring Gene Interplay in the Context of Long COVID.Int J Mol Sci. 2023 Oct 23;24(20):15471. doi: 10.3390/ijms242015471. Int J Mol Sci. 2023. PMID: 37895148 Free PMC article.
References
-
- Eakachai Prompetchara, Chutitorn Ketloy, Tanapat Palaga. Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic. Asian Pac J Allergy Immunol. 2020 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
